SLC3A2 and neoplasm: It has been reported that SLC3A2 deletion results in a downregulation of SLC7A11 levels, indicating that SLC3A2 is required to maintain SLC7A11 stability and its deficiency will impair the integrity of the system Xc−, thus sensitizing tumor cells to ferroptosis [30].